The current valuation score of BioRestorative Therapies Inc is 7.70, ranking 153 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.19, which is -14300.62% below the recent high of 27.27 and -1223.75% above the recent low of -2.54.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.